company background image
CENTRALPHL logo

Central Pharmaceuticals DSE:CENTRALPHL Stock Report

Last Price

৳20.10

Market Cap

৳2.4b

7D

-5.6%

1Y

57.0%

Updated

18 Jun, 2024

Data

Company Financials

Central Pharmaceuticals Ltd.

DSE:CENTRALPHL Stock Report

Market Cap: ৳2.4b

CENTRALPHL Stock Overview

Manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh.

CENTRALPHL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Central Pharmaceuticals Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Central Pharmaceuticals
Historical stock prices
Current Share Price৳20.10
52 Week High৳35.60
52 Week Low৳11.00
Beta0.062
1 Month Change2.03%
3 Month Change-30.93%
1 Year Change57.03%
3 Year Change58.27%
5 Year Change60.80%
Change since IPO1.14%

Recent News & Updates

Recent updates

Shareholder Returns

CENTRALPHLBD PharmaceuticalsBD Market
7D-5.6%1.1%0.1%
1Y57.0%-24.1%-26.6%

Return vs Industry: CENTRALPHL exceeded the BD Pharmaceuticals industry which returned -24.1% over the past year.

Return vs Market: CENTRALPHL exceeded the BD Market which returned -26.6% over the past year.

Price Volatility

Is CENTRALPHL's price volatile compared to industry and market?
CENTRALPHL volatility
CENTRALPHL Average Weekly Movement9.3%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.3%
10% most volatile stocks in BD Market7.7%
10% least volatile stocks in BD Market3.3%

Stable Share Price: CENTRALPHL's share price has been volatile over the past 3 months.

Volatility Over Time: CENTRALPHL's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of BD stocks.

About the Company

FoundedEmployeesCEOWebsite
198074Munsur Ahamedwww.centralphl.com

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It operates in Tablet, Capsule, Liquid, and Ointment segments. The company offers its products in various therapeutic areas, including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, musculoskeletal, dermatological, anti-diabetic, and oral rehydration salt.

Central Pharmaceuticals Ltd. Fundamentals Summary

How do Central Pharmaceuticals's earnings and revenue compare to its market cap?
CENTRALPHL fundamental statistics
Market cap৳2.41b
Earnings (TTM)-৳59.17m
Revenue (TTM)৳111.75m

21.5x

P/S Ratio

-40.7x

P/E Ratio

Is CENTRALPHL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CENTRALPHL income statement (TTM)
Revenue৳111.75m
Cost of Revenue৳126.90m
Gross Profit-৳15.15m
Other Expenses৳44.02m
Earnings-৳59.17m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.49
Gross Margin-13.56%
Net Profit Margin-52.95%
Debt/Equity Ratio33.7%

How did CENTRALPHL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.